Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d’Immunotherapie - Negrier, S; Escudier, B; Lasset, C (N Engl J Med, 1998)
et al.